SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-21-000074
Filing Date
2021-05-05
Accepted
2021-05-05 14:58:30
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 3-31-2021 form10q.htm   iXBRL 10-Q 1771028
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 14412
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 20459
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 13610
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 13459
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 7014
  Complete submission text file 0000874015-21-000074.txt   8428571

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ions-20210331.xsd EX-101.SCH 47444
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20210331_cal.xml EX-101.CAL 61434
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20210331_def.xml EX-101.DEF 315986
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20210331_lab.xml EX-101.LAB 776800
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20210331_pre.xml EX-101.PRE 427274
12 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1576405
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 21892768
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences